- Last edited on January 2, 2024
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
cl:3-mild-neurocog-disorder [on March 20, 2019] |
cl:3-mild-neurocog-disorder [on November 27, 2019] |
||
---|---|---|---|
Line 2: | Line 2: | ||
===== Primer ===== | ===== Primer ===== | ||
**Mild Neurocognitive Disorder** (also known as **Mild Cognitive Impairment**, or MCI) is a condition in which individuals demonstrate cognitive impairment with minimal impairment of instrumental activities of daily living (IADLs). Although it can be the first cognitive sign of [[geri:dementia:alzheimers|]], it can also be secondary to other disease processes (e.g. - neurologic, other neurodegenerative disorders, systemic, infectious, or psychiatric disorders). When there is //significant// impairment to daily function, a [[cl:2-major-neurocog-disorder|major neurocognitive disorder]] needs to be considered instead. | **Mild Neurocognitive Disorder** (also known as **Mild Cognitive Impairment**, or MCI) is a condition in which individuals demonstrate cognitive impairment with minimal impairment of instrumental activities of daily living (IADLs). Although it can be the first cognitive sign of [[geri:dementia:alzheimers|]], it can also be secondary to other disease processes (e.g. - neurologic, other neurodegenerative disorders, systemic, infectious, or psychiatric disorders). When there is //significant// impairment to daily function, a [[cl:2-major-neurocog-disorder|major neurocognitive disorder]] needs to be considered instead. | ||
+ | |||
===== Diagnostic Criteria ===== | ===== Diagnostic Criteria ===== | ||
<WRAP group> | <WRAP group> | ||
<WRAP half column> | <WRAP half column> | ||
== Criterion A == | == Criterion A == | ||
- | Evidence of **//modest//** cognitive decline from a previous level of performance in one or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual motor, or social cognition) based on: | + | Evidence of **//modest//** cognitive decline from a previous level of performance in ''1'' or more cognitive domains (complex attention, executive function, learning and memory, language, perceptual motor, or social cognition) based on: |
- Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | - Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive function; and | ||
- A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. | - A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment. |